Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Inderjit Singh

Inderjit Singh, Mount Pleasant, SC US

Patent application numberDescriptionPublished
20090111812METHODS FOR TREATING INFLAMMATORY DISORDERS - The present invention relates generally to the fields of molecular biology. More particularly, it concerns materials and methods for the treatment of nitric oxide and cytokind mediated disorders. In a preferred embodiment, PDMP may be used to inhibit the expression of iNOS and pro-inflammatory cytokines such as TNFα and IL1β.04-30-2009
20110059909METHODS FOR TREATING INFLAMMATORY DISORDERS - The present invention relates generally to the fields of molecular biology. More particularly, it concerns materials and methods for the treatment of nitric oxide and cytokind mediated disorders. In a preferred embodiment, PDMP may be used to inhibit the expression of iNOS and pro-inflammatory cytokines such as TNFα and IL1β.03-10-2011

Patent applications by Inderjit Singh, Mount Pleasant, SC US

Inderjit Singh, Ocean Beach, CA US

Patent application numberDescriptionPublished
20080209004FULL MESH RATES TRANSACTION IN A NETWORK - In one embodiment a communication method comprises the steps of receiving a query at Layer 2 from an entry node by way of a coordinated network, the query requesting data rates of network resources of the coordinated network; transmitting a Layer 2 request for an available data rate to each of a plurality of nodes connected to the coordinated network in response to the query; receiving a first Layer 2 response to said request from one or more of the plurality of nodes, wherein the first response includes a data rate with which each of the one or more nodes is capable of transmitting or receiving data; and transmitting a list of the received data rates to at least the entry node on the coordinated network.08-28-2008
20090323684DYNAMIC BITLOADING - The subject matter disclosed herein relates to dynamically adjusting bitloading for multiple destinations on a network.12-31-2009

Inderjit Singh, Mt. Pleasant, SC US

Patent application numberDescriptionPublished
20080227846METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS - The present disclosure describes methods for treating or preventing Type 1 diabetes mellitus in juveniles, particularly in juveniles newly diagnosed with Type 1 diabetes. This prevention or treatment of Type 1 diabetes is achieved by administering one or more therapeutic agents to a juvenile in need, wherein the therapeutic agent is, for example, a competitive inhibitor of mevalonate synthesis, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, or an inducer of AMP protein kinase (AMPK) activity. In certain embodiments, juveniles with Type 1 diabetes are treated with an HMG-CoA reductase inhibitor such as a statin, thereby decreasing the destruction of islet cells, or maintaining endogenous insulin production, in the juvenile.09-18-2008
20080275104METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS - The present disclosure describes methods for treating Type 1 diabetes mellitus in juveniles. This treatment of Type 1 diabetes is achieved by administering one or more therapeutic agents to a juvenile in need, wherein the therapeutic agent is, for example, a competitive inhibitor of mevalonate synthesis, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, or an inducer of AMP protein kinase (AMPK) activity. In certain embodiments, juveniles with Type 1 diabetes are treated with an HMG-CoA reductase inhibitor such as a statin.11-06-2008
20090192120INHIBITORS OF NITRIC OXIDE SYNTHASE - The current invention discloses novel methods for the inhibition of inducible nitric oxide synthesis (iNOS) and the production of NO. Methods of inhibiting the induction of proinflammatory cytokines are also described. Methods of treating various disease states, such as X-linked adrenoleukodystrophy, multiple sclerosis, Alzheimer's and septic shock using inhibitors of iNOS and cytokine induction are disclosed. The inhibitors include the exemplary compounds lovastatin, a sodium salt of phenylacetic acid (NaPA), FPT inhibitor II, N-acetyl cysteine (NAC), and cAMP.07-30-2009

Inderjit Singh, Saratoga, CA US

Patent application numberDescriptionPublished
20080266786METHOD AND APPARATUS FOR HEAT DISSIPATION - Embodiments of methods, apparatuses, devices, and/or systems for heat dissipation are disclosed.10-30-2008

Patent applications by Inderjit Singh, Saratoga, CA US